PT1560848E - Péptido imunogénico de ptprk - Google Patents

Péptido imunogénico de ptprk Download PDF

Info

Publication number
PT1560848E
PT1560848E PT03789032T PT03789032T PT1560848E PT 1560848 E PT1560848 E PT 1560848E PT 03789032 T PT03789032 T PT 03789032T PT 03789032 T PT03789032 T PT 03789032T PT 1560848 E PT1560848 E PT 1560848E
Authority
PT
Portugal
Prior art keywords
ptprk
immunogenic peptide
diagnosis
cells
cancer immunotherapy
Prior art date
Application number
PT03789032T
Other languages
English (en)
Inventor
Chiara Castelli
Giorgio Parmiani
Original Assignee
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Naz Stud Cura Dei Tumori filed Critical Ist Naz Stud Cura Dei Tumori
Publication of PT1560848E publication Critical patent/PT1560848E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/876—Skin, melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT03789032T 2002-11-14 2003-11-12 Péptido imunogénico de ptprk PT1560848E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002412A ITMI20022412A1 (it) 2002-11-14 2002-11-14 Peptidi immunogeni di ptprk.

Publications (1)

Publication Number Publication Date
PT1560848E true PT1560848E (pt) 2008-04-08

Family

ID=32310164

Family Applications (1)

Application Number Title Priority Date Filing Date
PT03789032T PT1560848E (pt) 2002-11-14 2003-11-12 Péptido imunogénico de ptprk

Country Status (12)

Country Link
US (1) US20060159691A1 (pt)
EP (1) EP1560848B1 (pt)
JP (1) JP2006506064A (pt)
AT (1) ATE383371T1 (pt)
AU (1) AU2003293677A1 (pt)
DE (1) DE60318608T2 (pt)
DK (1) DK1560848T3 (pt)
ES (1) ES2299748T3 (pt)
HK (1) HK1076476A1 (pt)
IT (1) ITMI20022412A1 (pt)
PT (1) PT1560848E (pt)
WO (1) WO2004043988A2 (pt)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863755A (en) * 1993-04-21 1999-01-26 Max Planck Gessellschaft Nucleic acid encoding novel receptor-type phosphotyrosine phosphatase-κ

Also Published As

Publication number Publication date
DE60318608T2 (de) 2009-01-15
HK1076476A1 (en) 2006-01-20
ES2299748T3 (es) 2008-06-01
AU2003293677A1 (en) 2004-06-03
EP1560848A2 (en) 2005-08-10
ITMI20022412A1 (it) 2004-05-15
DE60318608D1 (de) 2008-02-21
JP2006506064A (ja) 2006-02-23
DK1560848T3 (da) 2008-05-26
WO2004043988A8 (en) 2005-08-25
EP1560848B1 (en) 2008-01-09
US20060159691A1 (en) 2006-07-20
WO2004043988A3 (en) 2004-10-14
ATE383371T1 (de) 2008-01-15
WO2004043988A2 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
WO2002064057A3 (en) Use of cell penetrating peptides to generate antitumor immunity
HK1093014A1 (en) Microsome vaccine
HK1074670A1 (en) Sets of digital antibodies directed against short epitopes, and methods using same
AU2001298049A1 (en) Hla class i and ii binding peptides and their uses
MXPA05008128A (es) Peptidos derivados de survivina y uso de los mismos.
WO2001094944A3 (en) Artificial antigen presenting cells and methods of use thereof
CY1113044T1 (el) Παραλλαγματα αντιγονου αρχεγονων κυτταρων προστατη (psca) και υποαλληλουχιες εξ αυτων
CR8231A (es) Anticuerpos rg1 y uso de los mismos
ATE512666T1 (de) Hla-bindende peptide und ihre verwendungen
AU2003213580A1 (en) Subtilisin carlsberg proteins with reduced immunogenicity
HK1141540A1 (en) Hsp peptides and analogs for modulation of immune responses via antigen presenting cells hsp
AU2003242535A1 (en) Improved polysaccharide and glycoconjugate vaccines
TR200102034T2 (tr) Anti kanser aşılaması için antikorların kullanılması
AU7615900A (en) Isolated peptides which bind to mhc class ii molecules, and uses thereof
DE69720065D1 (de) Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen
HK1076476A1 (en) Ptprk immunogenic peptide
GB0203419D0 (en) Peptide
AU2003245781A1 (en) Mhc class ii peptide epitope of 5t4 antigen
AU5690400A (en) Novel compounds
EP2193804A3 (en) Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens
EP1572929A4 (en) BETA2 MICROGLOBULIN ANCHORED ON MEMBRANE COVALENTLY LINKED TO PEPTIDE EPITOPES OF MHC CLASS I
WO2003091383A3 (fr) Epitopes t de l'antigene epha2.
PT996636E (pt) Antigenio ha-1
AU2003217758A1 (en) Cytokines and cytokine receptors with reduced immunogenicity
AU2000273396A1 (en) Hla binding peptides and their uses